Terumo Blood and Cell Technologies

🎉 Celebrating a New Chapter in China 🎉 On November 14, 2024, we officially launched our localization initiative in China. Under the theme “Unlocking a New Chapter in China, Led by Purpose, Built on Quality” this milestone event brought together leaders from Terumo BCT, Terumo Corporation, Terumo China Holdings, and government representatives – all united in our commitment to "in China, for China." ✨ Highlights from the ceremony✨ - Announced our strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd (TMPH) for local manufacturing. - Committed $15M investment by 2025 to expand our business in China and support localized production of Trima Accel™ and Spectra Optia™ systems and disposable sets. - Strengthened ties within the Terumo Group as #OneTerumo. TMPH will be uniquely positioned to produce products from all three Terumo Companies—Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies . This initiative is more than just expanding our manufacturing capability. By establishing a stable and flexible local supply chain while maintaining global quality standards through unified quality management, we are positioning ourselves to better serve our Chinese customers and patients. A huge thank you to everyone who contributed to this milestone! Here’s to unlocking the potential of blood and cells for more patients in China. For full press release: (English): https://bit.ly/4fIUHiQ (Chinese): https://bit.ly/4fqk353 #TerumoBCT #ChinaLaunch #Localization #UnlockingPotential #TerumoProud #PatientCare

📢 We are proud to announce our strategic partnership with Terumo Medical Products (Hangzhou) to produce high-quality medical products for the Chinese market. “China is a pivotal market for Terumo BCT and the entire Terumo Group,” said Antoinette Gawin, President and CEO. “With our ‘in China, for China’ approach, we are committed to our long-term growth here. By 2025, we plan to invest USD 15 million to expand our business and localized manufacturing, enhancing our ability to meet the evolving needs of Chinese customers and improve patient outcomes in China.” Read more here: https://bit.ly/4fIUHiQ #PatientCare #OneTerumo #China

We’re excited to announce the launch of our new business area, designed to integrate disease expertise and elevate standards of care across the entire patient journey — from cell collections to therapy delivery. Led by Veerle d'Haenens, General Manager of Global Therapy Innovations, this will unite our teams in areas such as therapeutic apheresis and cell therapy for diseases such as sickle cell disease (SCD). By streamlining knowledge-sharing across platforms like the Spectra Optia Apheresis System, Quantum Flex Cell Expansion System, and FINIA Fill and Finish System, we aim to improve patient access to advanced therapies. Learn more about how we’re bridging the gap between cell collection, process standardization, and therapy delivery! https://bit.ly/48NvvoT #TherapeuticApheresis #CellTherapy #InnovationAndQuality #TerumoBCT #Healthcare

👩🔬 Celebrating STEM Day and Women in STEM In this article from Drug Target Review, Veerle d’Haenens, General Manager, Global Therapy Innovations, shares her career journey and advice to women aspiring #STEM jobs. Starting her career in very technical engineering roles, Veerle changed industries and responsibilities, into more commercially oriented roles in the life sciences sector – in pursuit of her interest and passion. This journey, she describes was a “natural evolution”. She advises young women too, to follow their personal motivators and topics of interest. But also to take care of yourself, to find a healthy balance between work and life. Read more of Veerle’s insights here: https://bit.ly/3NUQcpk #STEMDay #WomenInSTEM #STEMLeadership #DiversityInSTEM #CGT #CellandGeneTherapy #CellTherapy

“Cryopreservation stops the clock in manufacturing, easing the pressure of scheduling at the collection site from the patient to better align with manufacturing availability downstream,” says Trevor Smith, Senior Marketing Manager for Cell & Gene Therapy at Terumo BCT, in his latest interview with The Medicine Maker. Alongside experts Stella Vnook, CEO of Likarda , and Priya Baraniak, Ph.D., Co-Founder and Chief Business Officer of OrganaBio Trevor dives into the crucial role of cryopreservation in cell and gene therapy, the challenges it faces, and its future impact on healthcare. Catch the full article to see how these leaders envision new possibilities for cryopreservation in advanced therapies! https://lnkd.in/e7DMUrZK #CellAndGeneTherapy #Cryopreservation #TerumoBCT #InnovationandQuality

Agradecemos a todos los que pasaron por nuestro stand en el Congreso #ACOBASMET2024 para charlar con nuestros expertos y conocer nuestras soluciones. Mientras trabaja para hacer la diferencia en la atención al paciente, estamos aquí para respaldar cada paso, desde la recolección de sangre y células, hasta el procesamiento, el desarrollo de terapias y los servicios. Cuéntenos cómo podemos apoyar sus próximos pasos: https://bit.ly/3Uh2T1j #Hematología #Hemoterapia #TerapiaCelular #RecolecciónDeSangre

🎤 Oliver Bisazza, CEO of MedTech Europe, and Kristine Peers, General Counsel at EFPIA - European Federation of Pharmaceutical Industries and Associations, kick off the Healthcare Ethics & Compliance Conference #HETHICO! The opening panel, moderated by Anne-Sophie Bricca, Deputy General Counsel & Global Compliance Officer at Terumo Blood and Cell Technologies, delved into the evolving ethics and compliance landscape of the EU life sciences sector, focusing on the increasing alignment between the medical technology and pharmaceutical industries. MedTech Europe and EFPIA emphasised how compliance is a key enabler of broader business goals, helping to build trust and navigate evolving ethical expectations. Learn more about #HETHICO here ➡ https://bit.ly/47Kge7D

As we enter November and reflect on gratitude this Thanksgiving season, it’s a perfect time to recognize the importance of blood—a gift we may sometimes take for granted. Blood is vital medicine, supporting transfusions, cancer treatments, advanced gene and cell therapies, and more. In this short video, you’ll hear directly from patients about the impact of blood donations in their lives. Their stories remind us why it’s so crucial to ensure blood is always there when it’s needed most. And in the coming months, we’ll share more of their journeys and inspire new ways to give hope. Learn more at TerumoBCT.com/DropOfHope.

¡Ya estamos en el Congreso #ACOBASMET2024! Visítenos para aprender cómo la conectividad bidireccional entre sus dispositivos y TOMEs desbloquea funciones que apoyan su búsqueda de la excelencia operativa, permitiéndole lograr mayor consistencia, productividad, control y confianza en la calidad de atención al paciente. ¿Necesita más información? Contacte a nuestros representantes: https://bit.ly/3Uh2T1j #Hematología #Hemoterapia #TOMEs #BancosDeSangre #Innovación #TrimaAccel

Ya estamos en el Congreso #ACOBASMET2024, que se llevará a cabo hasta el domingo 3 de noviembre. Visite nuestro stand n.º 8 para conocer nuestras soluciones. Le compartimos un mensaje de Juan Duarte, Country Manager Colombia. ¿Necesita más información? Contacte a nuestros representantes: https://bit.ly/3Uh2T1j #ConUstedEnCadaPaso #Hematología #Hemoterapia #AnemiaFalciforme #RecolecciónDeCélulas